Skip to content

Fire acupuncture for postherpetic neuropain: a multicenter randomized controlled trial

Fire acupuncture for postherpetic neuropain: a multicenter randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR1900002624
Enrollment
Unknown
Registered
2019-09-26
Start date
2019-10-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postherpetic neuralgia

Interventions

Sponsors

The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Diagnostic and inclusion criteria To be eligible for the study, patients had to meet all thefollowing criteria: (1) Patients should be diagnosed with PHN (defined as persistent pain after one month from the disappearance of the herpes zoster rash); (2) Before clinic, the skin lesions of the herpes zoster should be treated with a normal course with enough duration. The herpes should be healed, or the crust should have fallen off. There remained abnormal sensations such as heat, cold, burn-like pain, needle-like pain, the electric shock sensation or touch-induced pain, hyperalgesia, numbness, itching in affected part of skin; (3) A pain scale of ?40mm on visual analogue scale(VAS); (4) The age should be between 18-70 years old; (5) No oral or external use of glucocorticoids; (6) Patients should be able to give written informed consent for study participation, understand procedures of this study, and complete patient-reported questionnaires adequately.

Exclusion criteria

Exclusion criteria: Any person who met any of the following criteria should be excluded: (1) The herpes zoster belonginged to a special type, such as eye zoster, ear zoster, visceral zoster, meningeal zoster, generalized zoster, etc. Those with new herpes at the time of visit should be excluded; (2) Those who were in pregnant, confinement or lactation period; (3) Those who were allergic to certain drugs; (4) Those with cicatricial diathesis; (5) Those with severe cardiovascular or cerebrovascular diseases, primary or secondary liver, kidney, hematopoiesis or immune system diseases. Those with diabetes, malignant tumor, mental diseases, diseases in connective tissue. Those with hemophilia or bleeding tendency.

Design outcomes

Primary

MeasureTime frame
VAS;

Secondary

MeasureTime frame
Pain threshold;ID Pain scale;pain scale;Mechanical allodynia, ALL;DN4 neuropathic pain scale;LANSS scale;Pricking threshold;SF-36 scale;Liver and kidney function;neuropathic pain symptoms inventory, NPSI;Ninjurin2;

Countries

China

Contacts

Public ContactGuohua Lin

The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine

tcmlin-801@163.com+86 13609021435

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026